Dr. Ain Uustare
Qualified Person, Head of R&D Department
Dr. Ain Uustare (PhD in Bioorganic Chemistry) joined TBD-Biodiscovery in 2008 as a Project Manager and in 2011 he took the position of the Head of Chemistry Department. His responsibilities included R&D projects management, supervision of contract manufacturing campaigns and providing instructions for Project Managers in the company. He has extensive experience in route-scouting, feasibility studies, process development, contract manufacturing, upscale and also synthesis of cytotoxics and HPAPI. Since 2008 Ain has also actively participated in the implementation of quality system in the company, developing documentation of standard operation procedures for manufacturing and process validation. Since 2011 he has also been the Production Manager in GMP-regulated manufacturing of active pharmaceutical ingredients, pre-formulations and excipients. Starting the 1st January 2018, Ain has became the Qualified Person in the company.
Mr. Ivan Ogibalov
Head of Production
Mr. Ivan Ogibalov (MSc in Organic Chemistry) joined TBD-Biodiscovery’s team in 2009 as a synthetic chemist. He always wanted his skill in organic synthesis to be useful to other people. He has contributed to many projects including customs synthesis and route-scouting of drug candidates, multistep synthesis of natural compounds, feasibility studies, upscale to multi-kilo level and contract manufacturing. In 2014 he became a Project Manager and shortly later a Senior Project Manager. He has supervised many R&D projects and has top-notch skills in the synthesis of oligopeptidomimetics, peptide linkers, cytotoxic peptides, aminoglycosides and experience in GMP-production. His responsibility was to guarantee the highest performance in the R&D projects and contract manufacturing. In January 2018 he became the Head of Production of the company.
Dr. Piia Liigand
Head of QC Laboratory
Piia Liigand (PhD in Chemistry) is highly experienced in the field of electrospray ionization mass spectrometry (ESI/MS) and other instrumental analyses (HPLC, GC, UV-VIS, IR, NMR etc). She has several years of experience working in ISO 17025:2005 certified laboratory of Testing Center of University of Tartu. She acquired a PhD in analytical chemistry in 2019. Her thesis was on the topic of ionization processes in electrospray ionization mass spectrometry with the ultimate aim to enable standard substance free quantification in ESI/MS.
Piia joined TBD-Biodiscovery at the end of 2018 as a Head of QC Laboratory. Her main responsibility is to manage, plan and lead the Quality Control laboratory. Her task is to ensure that the chemical analyses are performed according to proprietary methods and provide the highest quality of analytical support for development and manufacturing.
Ms. Kerli Martin
Head of QC Laboratory (Presently on the parental leave)
Kerli Martin (MSc in Analytical Chemistry) is experienced in the field of supramolecular chemistry, in determining the binding affinity of synthetic receptors, and in different instrumental analyses (ISE sensors, HPLC, GC, AAS, AES, UV-VIS, Fluroscence, NMR, cKF, etc). Kerli joined TBD-Biodiscovery in the fall of 2017 as a senior analytical chemist. In January 2018 she became a Head of QC Laboratory. Her main responsibility is to manage, plan and direct Quality Control laboratory to ensure the chemical analyses are performed according to proprietary methods and provide the highest quality analytical support for development and manufacturing, while ensuring compliance with protocols, GMP and safety regulations.
Dr. Andi Kipper
Deputy Head of R&D Department
Andi Kipper (MSc in organic chemistry) has been associated with TBD Biodiscovery since 2010. Initially he worked as a chemist and in 2013 he was promoted to project manager. His responsibilities included managing R&D projects both in the planning and the laboratory phase.
In 2014 he left the company to further his education and started PhD studies in the Leibniz University Hannover in Germany. He worked on total synthesis of polyketide natural products obtaining extensive knowledge on different synthetic methodologies. His expertise includes stereoselective synthesis, aldol reactions and boron-mediated organic transformations. He submitted his thesis in September 2018 and shortly after joined TBD Biodiscovery’s R&D department. In January 2019 he was promoted to Deputy Head of R&D Department.